Laparoscopic Single-site Surgery Versus Conventional Entry in Ovarian Cystectomy

Sponsor
Ain Shams University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04788498
Collaborator
(none)
74
2
24

Study Details

Study Description

Brief Summary

The aim of this work is to evaluate the postoperative consequences of laparoendoscopic single site surgery relative to conventional laparoscopy in presumed benign ovarian cyst.

The hypothesis is that single incision technique might offer advantages over the standard multi-port laparoscopy as potentially leading to less postoperative pain and improved cosmoses from a relatively hidden umbilical scar, as well as risk reduction of postoperative wound infection, hernia formation and elimination of multiple trocar site closure

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoendoscpoic single site surgery LESS
  • Procedure: Conventional multiport laparoscopy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
74 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Laparoendoscopic Single-site Surgery Versus Conventional Multi-port Laparoscopy in Presumed Benign Ovarian Cystectomy: A Randomized Controlled Trial
Anticipated Study Start Date :
May 1, 2021
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Laparoendoscpoic single site surgery LESS

35 patients undergoing laparoscopic ovarian cystectomy A SILS Port (Covidien®) with three access inlets will be inserted into the abdominal cavity using a Heaney clamp

Procedure: Laparoendoscpoic single site surgery LESS
• A SILS Port (Covidien®) with three access inlets will be inserted into the abdominal cavity using a Heaney clamp

Active Comparator: Conventional multiport laparoscopy

35 patients undergoing laparoscopic ovarian cystectomy It will be performed using a three-port system using a closed technique on the umbilicus, left and right lower quadrant area.

Procedure: Conventional multiport laparoscopy
• It will be performed using a three-port system using a closed technique on the umbilicus, left and right lower quadrant area.

Outcome Measures

Primary Outcome Measures

  1. Postoperative pain [at 24 hours ± 2 hour after the intervention]

    The pain will be assessed by a numeric rating scale of 0-10

Secondary Outcome Measures

  1. Operative time [intraoperative]

    the time between the start of the incision up to the cutaneous closing of the trocar orifices

  2. the need for conversion to laparotomy [intraoperative]

    the need for conversion to laparotomy

  3. the need to add an additional trocar [intraoperative]

    the need to add an additional trocar

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patients are aged 18 to 45 years with BMI < 35 kg/m2 and that they exhibit a surgical indication for a presumed benign ovarian pathology (PBOP) according to RCOG
Guideline no. 62. 2011:
  • simple ovarian cysts >7cm and <15cm.

  • Persistent simple cyst for more than 3 months.

  • Symptomatic patients with complicated cyst (e.g. hemorrhagic cyst, torsion, etc)

Exclusion Criteria:
  • • Previous midline laparotomies as suspected massive adhesions affecting intraoperative maneuvers and time.

  • Chronic pelvic pain, endometriosis or pelvic inflammatory diseases will be excluded to avoid pelvic adhesions and bias in the quantification of postoperative pain.

  • Do not possess a native umbilicus giving difficult access to single port.

  • The 'risk of malignancy index' (RMI) should be used to exclude those women at greater risk of malignancy. Using an RMI cut-off of 200, a sensitivity of 70% and specificity of 90% can be achieved. if features suggestive of malignancy are encountered, a gynecological oncologist should be consulted regarding further evaluation and staging.

  • Benign teratomas for the difficulty of extraction after removal that affects the intraoperative maneuvers and time.

  • Contraindication to any laparoscopy like any medical condition worsened by pneumoperitoneum or the Trendelenburg position.

  • Contraindication to general anesthesia as all laparoscopic procedures are done under GA.

  • Contraindication to non-steroidal anti-inflammatories, paracetamol, or tramadol.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ain Shams University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mahmoud Nabil, Doctor, Ain Shams University
ClinicalTrials.gov Identifier:
NCT04788498
Other Study ID Numbers:
  • M D 34 / 2021
First Posted:
Mar 9, 2021
Last Update Posted:
Mar 9, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2021